Recent studies of timing of dialysis initiation have challenged the recent trend to earlier
initiation of therapy. The observed outcomes though are a consequence of the balance …

Despite many medical and socioeconomic advantages, peritoneal dialysis (PD) is an
underutilized dialysis modality that in most countries is used by only 5%–20% of dialysis …

Background Dialysis patients have an exceedingly high mortality rate. Biomarkers may be
useful tools in risk stratification of this population. We evaluated the prognostic value of high …

End-stage renal disease (ESRD) is on the rise worldwide. 1 In the United States alone,
approximately 124,500 patients with ESRD began dialysis in 2017 according to the United …

Heart failure is a significant health problem worldwide. Despite all the new therapies
available nowadays, many patients will reach advanced stages of the disease. Diuretic …

Introduction: High ultrafiltration (UF) rates can result in intradialytic hypotension and are
associated with increased mortality. The effects of a weight‐based UF rate limit on …

Background: Ultrafiltration is an alternative strategy to diuretic therapy for the treatment of
patients with acute decompensated heart failure. Little is known about the efficacy and safety …

Hemodialysis (HD) is a life-saving treatment for patients with kidney failure. However,
patients requiring HD have a 10-20 times higher risk of cardiovascular (CV) morbidity and …

Rates of cardiovascular mortality are disproportionately high in patients with end stage
kidney disease receiving dialysis. However, it is now generally accepted that patient survival …

Aims: To investigate if a single low-flux HD induces a rise in cardiac biomarkers and if a
change in clinical approach may limit such mechanism. Material and methods: A total of 20 …